Aldeyra Therapeutics
(NASDAQ) ALDX
Aldeyra Therapeutics Financials at a Glance
Market Cap
$108.33M
Revenue (TTM)
$0.00
Net Income (TTM)
$33.85M
EPS (TTM)
$-0.56
P/E Ratio
-3.19
Dividend
$0.00
Beta (Volatility)
1.79 (High)
Dividend
$0.00
Beta (Volatility)
1.79 (High)
Price
$1.80
Volume
1,292,794
Open
$1.81
Price
$1.80
Volume
1,292,794
Open
$1.81
Previous Close
$1.80
Daily Range
$1.79 - $1.86
52-Week Range
$1.07 - $6.17
Dividend
$0.00
Beta (Volatility)
1.79 (High)
Price
$1.80
Volume
1,292,794
Open
$1.81
Previous Close
$1.80
Daily Range
$1.79 - $1.86
52-Week Range
$1.07 - $6.17
ALDX News
ALDX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Aldeyra Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
8
CEO
Todd C. Brady, MD, PhD
Website
www.aldeyra.comHeadquarters
Lexington, MA 02421, US
ALDX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-59%
Return on Capital
-80%
Return on Assets
-47%
Earnings Yield
-31.35%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$108.33M
Shares Outstanding
60.18M
Volume
1.29M
Short Interest
0.00%
Avg. Volume
3.05M
Financials (TTM)
Gross Profit
$251.99K
Operating Income
$35.27M
EBITDA
$31.69M
Operating Cash Flow
$33.35T
Capital Expenditure
$0.00
Free Cash Flow
$33.35T
Cash & ST Invst.
$70.04M
Total Debt
$15.53M
Aldeyra Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$65.11K
-1.2%
Gross Margin
0.00%
N/A
Market Cap
$108.33M
N/A
Market Cap/Employee
$12.04M
N/A
Employees
9
N/A
Net Income
$6.46M
+59.1%
EBITDA
$1.09T
+7106395.2%
Quarterly Fundamentals
Net Cash
$54.51M
-36.5%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$15.53M
+5025.4%
Return on Assets
-46.97%
N/A
Return on Invested Capital
-79.69%
N/A
Free Cash Flow
$28.20T
+234241228.0%
Operating Cash Flow
$28.20T
+234241228.0%